Lee, MD, MSc JAMA Editorial Seeking Balance Between Pain Relief and Safety William Renthal, MD, PhD JAMA Neurology Editorial CDC Guideline for Prescribing Opioids for Chronic Pain Neil L. Schechter, MD; Gary A. Walco, PhD JAMA Pediatrics Editorial Opioid Prescribing for Chronic Pain Mitchell H....
“In many discussions regarding opioid use, health insurance providers have stressed the importance of evaluating what outcomes a patient seeks to achieve from pain treatment, considering nonpharmaceutical and non-opioid options, and appropriately communicating with patients about what can and...
Objective: Opioid analgesics may be prescribed to ankylosing spondylitis (AS) patients with pain that is unresponsive to antirheumatic treatment. Our study assessed factors associated with opioid usage in AS. Methods: A prospective cohort of 706 patients with AS meeting modified New York criteria follo...
Concerns With Statistical Analysis of 2016 CDC Opioid Guideline and Sickle Cell Outcomesdoi:10.1001/jamainternmed.2024.3019Patel, Ashwin P.McLemore, MorganSheehan, Vivien A.JAMA Internal Medicine
They expected physician and FDA opioid hesitancy to remain high in that area. But the FDA quickly approved not only the new drug but its descriptive package insert, which included the words “Delayed absorption, as provided by OxyContin tablets, is believed to reduce the abuse liability.” That...
“In 2016, CDC first released an opioid-prescribing guideline for chronic pain, and while well-intentioned, dosage thresholds and other aspects of the guideline were incorporated into laws, regulations, and policies that resulted in severe, unintended consequences for some patients. “Most notably...
Numerous pain management experts and medical groups are urging the Centers for Disease Control and Prevention (CDC) to revise and broaden the scope of a 2016 opioid prescribing guideline that they say has harmed many patients who have been subject to forced tapering or discontinuation of opioid ...
Mixed Reaction from Professional Groups on CDC Opioid GuidelinePoor pain control after orthopaedic trauma is a predictor of physical disability and numerous negative long-term outcomes. Despite increased awareness of the negative consequences of poorly controlled pain, analgesic therapy among...
There was also a significant decrease in the rate of concomitant opioid and benzodiazepine prescribing as well as average days' supply per prescription in the postguideline cohort, as compared with the preguideline cohort.CONCLUSIONS:The average MEDD prescribed in the ED of an academic medical ...
Background: National surveys show that primary care physicians feel responsible for addressing the opioid epidemic. They feel their training in managing chronic pain and addiction was insufficient, and commonly endorse the need for more residency training in these areas. However, residency training in ...